Biopsy in Adult CeD (Bio.A.CeD)- the ESsCD Consensus

Biopsy in Adult CeD (Bio.A.CeD)- the ESsCD Consensus - Biopsy in Adult CeD (Bio.A.CeD)- the ESsCD Consensus

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON48090

Enrollment

Registered

2019-07-29

Start date

2019-11-20

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coeliac disease

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: indication for biopsy in suspected celiac disease

Exclusion criteria

Exclusion criteria: nvt

Design outcomes

Primary

Measure	Time frame
1) to know the predictive value of serology in the diagnosis of CeD in a high-risk population (seropositive or high clinical suspicion) 2) to determine the serology cut-off best suited to predict the presence of small bowel duodenal damage diagnostic for CD (Marsh > 2 and Marsh 3 separately)	—

Countries

Netherlands

Outcome results